The approach we support at the University of Manchester focuses on Analyzing the tumor microenvironment and its immune cells to find existing drugs for vestibular schwannoma (VS) and meningioma tumors in NF2. Learn more here: https://t.co/h8saCyNnQX
#endnf2! “The majority (91%) reported that their NF symptoms had at least some impact on daily life. In the total sample, 51% endorsed a mental health diagnosis, and 27% without a diagnosis believed they had an undiagnosed mental health condition.” https://t.co/qUbl7HOnsx
Two hundred years ago, people launched a resistance movement against algorithmic thinking and technocratic dominance. Their actions transformed the creative culture and larger society.
Could it happen again? https://t.co/pXenG5xXdR
If Elon Musk hadn’t bought X, no one sees those Hamas videos. American media would have blurred. Twitter was supportive of Hamas and would have banned them as graphic content. Israel would be accused of attacking for no reason. Not seeing more people defend Elon is mind blowing.
I was wearing a #BeastieBoys shirt while eating at a restaurant the other day. I had to sneeze and the only way to be polite was to conceal it by sneezing on my shirt. I was like, oh man. I sneezed on Adrock. Then I did it again on mike D. I'm sorry.
Visit our website to read our Sponsored Research 2023 Update.: https://t.co/OxXm6KQ9qs
Thanks to the unwavering support of our volunteers, ambassadors, and donors, we have been able to jumpstart and support the following research initiatives and tools.
Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a NF-2 Patient. “Treatment with the ARB telmisartan together with bevacizumab resulted in improved hearing, reduced proteinuria, and controlled hypertension.” https://t.co/NROTn4FrsB